News
During a live event, Jorge Monge, MD, discussed short and long-term adverse events associated with CAR T-cell therapy in ...
A pioneering reproductive technology reduced the risk of children inheriting disease-causing mutations in mitochondria, researchers reported.
INDIANAPOLIS (WISH) — it’s a type of aggressive skin cancer that is the fifth most deadly cancer. Surgery, immunotherapy and chemo are the typical treatments. But now, the FDA has approved a ...
Chemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that ultimately may make the ...
RNA bundled in lipid nanoparticles trains T cells in mice to eliminate cancer. Coupled with noninvasive imaging, researchers ...
Dr. Olalekan O. Oluwole explained how CAR T is used to treat high-risk blood cancers and highlighted the potential of ...
The concept of using proteins and other secreted factors to treat heart attack, rather than replacement cells, has emerged.
For the past 20 years, many of the dramatic improvements in cancer outcomes can be attributed to personalized cancer ...
MIT researchers have developed a new theoretical framework for studying the mechanisms of treatment interactions. Their ...
Outpatient CAR T therapy has reduced hospital stays by two-thirds while maintaining safety for those with blood cancers, according to Dr. Olalekan Oluwole.
19h
MedPage Today on MSNCMS Rolls Out Value-Based Gene Therapy Model for Sickle Cell DiseaseLast December, CMS announced that the two SCD gene therapy manufacturers -- Vertex Pharmaceuticals and bluebird bio -- agreed to participate in the model.
Advances in blood stem cell transplants now make it possible for people with blood cancers to get safe and effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results